National Health Investors (NYSE:NHI) Share Price Breaks Below 50-Day Moving Average – Should You Sell?

National Health Investors, Inc. (NYSE:NHI)’s stock price passed below its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $67.62 and traded as low as $65.30. National Health Investors shares last traded at $66.2340, with a volume of 485,523 shares changing hands.

Key National Health Investors News

Here’s some of the latest news about NHI:

• Positive Sentiment: Huntington initiated coverage with a “strong-buy” rating, adding a bullish analyst view. Huntington stock recommendations
• Positive Sentiment: Management is targeting high-single- to low-double-digit organic NOI growth in its SHOP portfolio for 2026, signaling expectations for continued growth in that business. NHI 2026 NFFO guidance and SHOP growth targets
• Negative Sentiment: 2026 NFFO guidance of $4.68–$4.70 per share is below the $4.76 consensus estimate, which could weigh on earnings expectations. NHI full-year 2026 earnings guidance

Analyst Ratings Changes

A number of research firms recently weighed in on NHI. Zacks Research raised shares of National Health Investors from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. Truist Financial dropped their target price on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, September 2nd. Wells Fargo & Company cut their target price on National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Huntington began coverage on National Health Investors in a report on Monday. They issued a “strong-buy” rating on the stock. Finally, National Bank Financial set a $79.00 price target on National Health Investors in a report on Wednesday, September 9th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and an average target price of $81.00.

National Health Investors Stock Down 2.3%

The company has a market cap of $3.25 billion, a PE ratio of 4.65, a P/E/G ratio of 4.39 and a beta of 0.51. The company’s 50 day moving average is $67.62 and its 200 day moving average is $76.01. The company has a current ratio of 13.59, a quick ratio of 6.78 and a debt-to-equity ratio of 0.50.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $10.29. The company had revenue of $113.48 million during the quarter, compared to analysts’ expectations of $68.53 million. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. As a group, analysts predict that National Health Investors, Inc. will post 4.69 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be issued a $0.92 dividend. The ex-dividend date is Thursday, December 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.6%. National Health Investors’s payout ratio is presently 26.40%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc grew its position in shares of National Health Investors by 108.5% during the 3rd quarter. Versant Capital Management Inc now owns 415 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 216 shares in the last quarter. Compass Wealth Management LLC bought a new stake in shares of National Health Investors in the third quarter valued at about $31,000. GAMMA Investing LLC raised its holdings in shares of National Health Investors by 38.0% in the third quarter. GAMMA Investing LLC now owns 603 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 166 shares in the last quarter. Allworth Financial LP bought a new stake in shares of National Health Investors in the second quarter valued at about $42,000. Finally, EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 34.3% in the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust’s stock worth $51,000 after acquiring an additional 160 shares during the period. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

About National Health Investors

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.